ACLY ubiquitination by CUL3-KLHL25 induces the reprogramming of fatty acid metabolism to facilitate iTreg differentiation | eLife
An allosteric mechanism for potent inhibition of human ATP-citrate lyase | Nature
ACLY and AR inhibition promotes AMPK activation without suppressing... | Download Scientific Diagram
ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch. - Abstract - Europe PMC
Dysregulated lipid metabolism blunts the sensitivity of cancer cells to EZH2 inhibitor - eBioMedicine
Antitumor effects of curcumin: A lipid perspective - Naeini - 2019 - Journal of Cellular Physiology - Wiley Online Library
Tyrosine phosphorylation is critical for ACLY activity in lipid metabolism and cancer | bioRxiv
Mendelian Randomization Study of ACLY and Cardiovascular Disease | NEJM
ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: An updated review - ScienceDirect
Cancers | Free Full-Text | ACLY (ATP Citrate Lyase) Mediates Radioresistance in Head and Neck Squamous Cell Carcinomas and is a Novel Predictive Radiotherapy Biomarker | HTML
Inhibitors of lipogenic enzymes as a potential therapy against cancer - Montesdeoca - 2020 - The FASEB Journal - Wiley Online Library
Tyrosine phosphorylation is critical for ACLY activity in lipid metabolism and cancer | bioRxiv
ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism - ScienceDirect
Frontiers | Exploring the Role of ATP-Citrate Lyase in the Immune System | Immunology
ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism - ScienceDirect
Validation of ACLY as a specific target of DCV with a recombinant... | Download Scientific Diagram
The multifaceted therapeutic value of targeting ATP-citrate lyase in atherosclerosis: Trends in Molecular Medicine
Targeted inhibition of ACLY expression to reverse the resistance of sorafenib in hepatocellular carcinoma
The ATP-citrate Lyase (ACLY) Project
ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism - ScienceDirect
IJMS | Free Full-Text | NASH, Fibrosis and Hepatocellular Carcinoma: Lipid Synthesis and Glutamine/Acetate Signaling | HTML
Targeted inhibition of ACLY expression to reverse the resistance of sorafenib in hepatocellular carcinoma
